Status:
RECRUITING
Skin Reactions Related to Thoracic Implantable Chamber Dressings
Lead Sponsor:
Institut Curie
Conditions:
Skin Diseases
Eligibility:
All Genders
18-100 years
Brief Summary
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic im...
Detailed Description
The Implantable Catheter Chamber (ICC) has been in use since the 1980s. It enables the administration of nutrition and/or venotoxic and cytotoxic treatment without altering the patient's venous capita...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- New chemotherapy patients (1st line of treatment only)
- Thoracic PAC
Exclusion
- PICC Line and femoral PAC;
- Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
- Disunion requiring treatment
- Patients treated for hematological cancer;
- Persons deprived of their liberty or under guardianship (including curatorship);
- Adults under court protection;
- Inability to participate in the study for geographical, social or psychological reasons.
- No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.).
- Opposition to data use
Key Trial Info
Start Date :
June 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07158879
Start Date
June 10 2025
End Date
December 10 2026
Last Update
September 8 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75248
2
Centre Hospitalier de Polynésie Française CHPF
Pirae, French Polynesia, 98716
3
Hôpital Uturoa
Uturoa, French Polynesia, 98735